5/2/2022 | BK | Allscripts amends and restates revolver, downsizes to $700 million
|
4/29/2022 | SP | New Issue: GS Finance sells $9.11 million basket-linked notes tied to 49 stocks
|
10/14/2020 | CV | Market Commentary: Redfin on tap; Royal Caribbean volatile; Nova trades up; Allscripts skyrockets
|
12/20/2019 | CV | Allscripts greenshoe increases 0.875% convertibles to $218 million
|
12/6/2019 | CV | Market Commentary: Twitter convertible notes in focus following junk bond pricing; Caesars, Intel active
|
12/6/2019 | CV | Market Commentary: Morning Commentary: Twitter convertible notes in focus following junk bond pricing
|
12/5/2019 | CV | Market Commentary: Allscripts Healthcare convertible notes hit the market, trade tight; RH gains outright
|
12/5/2019 | CV | Market Commentary: Morning Commentary: Allscripts Healthcare convertible notes hit the market, trade tight
|
12/5/2019 | CV | New Issue: Allscripts prices $200 million seven-year convertibles to yield 0.875%, up 32.5%
|
12/4/2019 | CV | Market Commentary: Allscripts convertibles offering eyed; Chesapeake in focus; Liberty Media notes active
|
12/4/2019 | CV | Market Commentary: Morning Commentary: Allscripts convertibles offering on tap, viewed as 1.5 points cheap
|
12/3/2019 | CV | Market Commentary: Allscripts on tap; Cleveland-Cliffs contracts on acquisition news; Trip.com, Tesla active
|
12/3/2019 | CV | Allscripts talks $200 million seven-year convertible notes to yield 0.75%-1.25%, up 30%-35%
|
2/22/2019 | CV | Market Commentary: Wayfair, Allscript, Infinera, Zillow convertibles expand; Karyopharm Therapeutics tanks
|
11/2/2018 | CV | Market Commentary: Allscripts Healthcare convertibles contract; MercadoLibre notes expand; Boingo weakens
|
11/2/2018 | CV | Market Commentary: Morning Commentary: Allscripts Healthcare convertibles in focus, contract post-earnings
|
2/15/2018 | BK | Allscripts upsizes term loan to $400 million, revolver to $900 million
|
4/25/2016 | BK | Netsmart closes $612 million loans to help fund merger with Allscripts
|
12/1/2015 | CV | Market Commentary: Planned Nuance convertibles slightly cheap; Teva deal timing accelerated; Inphi on tap
|
12/1/2015 | CV | Market Commentary: Morning Commentary: Planned Nuance slightly cheap; existing Nuance in line; Allscripts up with stock
|
10/2/2015 | BK | Allscripts refinances facility with $800 million term loan, revolver
|
6/30/2015 | PP | Allscripts takes in $100 million through private placement of shares
|
4/21/2015 | SP | New Issue: JPMorgan prices $234,000 contingent absolute return autocallables linked to Allscripts
|
4/15/2015 | SP | JPMorgan plans contingent absolute return autocallables on Allscripts
|
2/20/2015 | SP | New Issue: JPMorgan prices $1 million digital notes linked to Allscripts
|
11/12/2014 | PP | Market Commentary: New Isis Pharmaceuticals trades below par, slips on hedge; Dendreon steady; Home Inns adds
|
11/12/2014 | CV | Market Commentary: New Isis Pharmaceuticals trades below par, slips on hedge; Dendreon steady; Home Inns adds
|
11/11/2014 | CV | Market Commentary: Existing Isis bonds, shares up; planned Isis looks slightly rich; Ascent Capital shares drop
|
11/7/2014 | PP | Market Commentary: Salix Pharmaceuticals slumps outright, adds on heavy deltas; Allcripts Healthcare drops
|
11/7/2014 | CV | Market Commentary: Salix Pharmaceuticals slumps outright, adds on heavy deltas; Allcripts Healthcare drops
|
11/7/2014 | CV | Market Commentary: Morning Commentary: Salix slumps on earnings miss, lowered guidance; AllScripts Healthcare drops
|
7/10/2013 | CV | Market Commentary: Tesla steady at highs; Allscripts expands on hedge; Vantage Drilling, Merrimack on tap
|
7/2/2013 | BK | Allscripts Healthcare gets $650 million five-year term loan, revolver
|
6/18/2013 | CV | Allscripts greenshoe exercised, lifting convertibles to $345 million
|
6/13/2013 | CV | New Issue: Allscripts Healthcare sells $300 million seven-year convertibles at 1.25%, up 30%
|
6/13/2013 | CV | Market Commentary: Allscripts up on debut; new Take-Two trades under par; Halcon quiet after quick marketing
|
6/12/2013 | CV | Allscripts Healthcare to sell $300 million seven-year convertibles at 1%-1.5%, up 27.5%-32.5%
|
6/12/2013 | CV | Market Commentary: Workday trades around par on debut; Cornerstone better with shares; four deals on deck
|
4/29/2013 | BKCV | S&P trims Allscripts Healthcare rating
|
6/27/2012 | BKCV | S&P rates Allscripts loan BBB
|
6/12/2012 | BK | Allscripts Healthcare Solutions gets $150 million incremental term loan
|
5/25/2012 | BKCV | Moody's rates Allscripts loan Ba2
|
4/27/2012 | BKCV | S&P cuts Allscripts outlook
|
7/28/2011 | BKCV | S&P upgrades Allscripts
|
4/6/2011 | BK | Allscripts Healthcare amends and restates loan to reduce pricing
|
2/15/2011 | BK | Allscripts pays down $81 million of bank borrowings since August
|
8/23/2010 | BK | Market Commentary: Strategic Partners breaks; Advance Pierre structure emerges; Valeant firms timing; Cenveo pulled
|
7/28/2010 | BK | Market Commentary: Vertafore, GEO, Universal Health break; Las Vegas Sands rallies; TI Auto, Savvis tweak deals
|
7/28/2010 | BK | Allscripts lifts term A to $470 million, revolver to $250 million
|
7/23/2010 | BK | Allscripts likely to drop $250 million term loan B, upsize pro rata
|
7/23/2010 | BK | Market Commentary: Kenan Advantage breaks; Ford up with earnings; Ntelos sets talk; Allscripts changes expected
|
7/14/2010 | BK | Allscripts $250 million term loan B may launch during July 26 week
|
7/14/2010 | BK | Market Commentary: Gun Lake, Ocwen break; Cedar Fair changes expected; Kenan tweaks deal; Bryant OID emerges
|
7/8/2010 | BK | Market Commentary: Skilled Healthcare rises; Ocwen firms OID; Interactive, Fidelity tweak; Allscripts sets talk
|
7/8/2010 | BK | Allscripts launches $150 million revolver, $320 term loan A at Libor plus 325 basis points
|
7/7/2010 | BK | Allscripts reveals loan split of $320 million term loan A and $250 million term loan B
|
7/7/2010 | BK | Market Commentary: Skilled Healthcare plummets; LNR pulls loan; AL Gulf tweaks deal; Gentiva, Vertafore set talk
|
7/6/2010 | BK | Allscripts to launch term loan A on Thursday; term loan B to follow
|
7/6/2010 | BK | Market Commentary: Dynegy under pressure; Hearthside Food, Vision Solutions tweak deals; inVentiv adds lead
|
7/1/2010 | BK | Allscripts $720 million credit facility expected to launch next week
|
7/1/2010 | BK | Market Commentary: Willbros breaks; Gentiva retail timing emerges; Allscripts readies launch; Insight tweaks deal
|
6/14/2010 | BK | Allscripts planned $570 million term loan to include 1.5% Libor floor
|
6/9/2010 | BK | Allscripts plans new $720 million credit facility to fund purchase of shares from Misys
|
6/9/2010 | BK | Market Commentary: AutoTrader.com, Cincinnati Bell break for trading; LNR tweaks pricing; Silgan details emerge
|
6/10/2009 | CV | Allscripts 3.5% debentures now convertible through end of quarter
|
10/13/2008 | SS | Allscripts Healthcare acquires Misys Healthcare
|
10/10/2008 | CVSS | Allscripts sets special cash dividend amount at $5.23
|
10/6/2008 | SS | Allscripts, Misys transaction could close Friday following receipt of stockholder approval
|
9/29/2008 | SS | Misys funding in place for merger; Allscripts to pay dividend on Oct. 17
|
8/22/2008 | SS | Allscripts shareholders to decide merger with Misys on Sept. 22
|
8/20/2008 | BK | Allscripts gets $75 million amended and restated revolver
|
3/18/2008 | SS | Misys Healthcare, Allscripts Healthcare to combine
|
3/18/2008 | SS | Market Commentary: Others poaching for Bear; pilot communications end; Yahoo! fights on; Alliance eggs on Blackstone
|
2/14/2008 | CV | Market Commentary: Delta investors flee Allscripts, flock to Equinix; Molina, Amkor up; cost-cutting helps Advanced Medical Optics
|
11/16/2007 | CV | Defensive convertibles provide safety in a volatile market, Lehman Brothers report says
|
11/18/2005 | CVHY | Allscripts files $200 million shelf
|
6/30/2004 | CV | Allscripts Healthcare $75 million convertible yields 3.5%, up 40%
|
6/30/2004 | CV | Market Commentary: Market watches Fed; Allscripts, General Mills and Watson Pharmaceuticals trade
|
6/29/2004 | CV | Allscripts Healthcare $75 million convertible talked at 3%-3.5%, up 38%-42%
|